Newsfeeds - Spark Newswire

3 minute read

News

Allego Commissions 4 Electric Vehicle Fast-Charging Hubs On The VINCI Autoroutes Network

Today, 8:12 AM

Committed to supporting the development of low-carbon mobility, VINCI Autoroutes continues to deploy electric vehicle (EV) fast-charging hubs on its network. Today, to accommodate those who will take to the road in

ALLG

1 minute read

Hibbett, Enfusion And Some Other Big Stocks Moving Lower On Tuesday

By Lisa Levin

Today, 8:12 AM

U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

ABCM

1 minute read

Allego Q3 Sales €22.32M Up From €10.89M YoY. Net Loss of €18.72M Down From €80.46M YoY

By Benzinga Newsdesk

Today, 8:12 AM

Allego (NYSE:ALLG) reported €22.32 million in sales this quarter. This is a 104.96 percent increase over sales of €10.89 million the same period last year.

ALLG

17 minute read

Earnings

Earnings Scheduled For November 14, 2022

By Benzinga Insights

Today, 8:12 AM

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

AAIC

8 minute read

Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday

By Lisa Levin

Today, 8:12 AM

Gainers

$APE

9 minute read

Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 8:12 AM

On Monday, 160 companies hit new 52-week lows.

$APE

23 minute read

News
Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 8:12 AM

On Monday, 413 companies reached new 52-week lows.

AAN

5 minute read

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday

By Lisa Levin

Today, 8:12 AM

Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial met its primary endpoint.

ABOS